← All stocks

Compass Therapeutics, Inc.

CMPX No buying or selling
CIK 0001738021 #3229 in the set updated 18 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
$0.00
$0.00 against sales at will

By person

6 insiders · 0 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Schuetz Thomas J.
CHIEF EXECUTIVE OFFICER
6,603,336
$13.93M
+0.5%
Shin Barry
CFO
525,000
$1.11M
Lerner Neil
Chief Accounting Officer
397,500
$838.73K
+32.5%
Anderman Jonathan
General Counsel
196,000
$413.56K
+19,500%
ORBIMED ADVISORS LLC entity
Director
0
$0.00
−100.0%
GORDON CARL L
Director
0
$0.00
−100.0%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 0
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 23 Jun 2020